Extensive clinical research ensures safe, comfortable use. Dr. Ji’s study was presented at 2019 ADA and published in a Lancet journal.

Our jet injector improves glucose & insulin control better than pens in T2DM patients. It is easy to use with high acceptance and good tolerance.

GluBud delivers faster, higher insulin absorption than pens, with stronger early glucose lowering. It closely mimics natural early-phase insulin secretion.

Needle-free injection offers better safety by reducing skin irritation, pain, indurations and the risk of broken needles compared to insulin pens.

The needle-free injector significantly improves quality of life and treatment satisfaction for T2DM patients over traditional insulin pen use.

Needle-free injection achieves non-inferior glycemic control, higher satisfaction and better safety. It also improves long-term glucose control with glargine.